No Detail Found!

RP-HPLC method to assay ethinylestradiol and drospirenone with 3D chromatograph model in fixed dose in rat plasma for pharmacokinetic study analysis

Author(s)
Yasir Mehmood Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Government College University, Faisalabad, Pakistan; Riphah Institute of Pharmaceutical Sciences (RIPS), Riphah International University, Faisalabad, Pakistan
Hira Shahid Department of Pharmacology, Faculty of Pharmaceutical Sciences, Government College University,Faisalabad,Pakistan
Hammad Yousaf Rashid Latif College of Pharmacy, Rashid Latif Khan University,Lahore,Pakistan
Humayun Riaz Rashid Latif College of Pharmacy, Rashid Latif Khan University,Lahore,Pakistan
Umar Farooq Rashid Latif College of Pharmacy, Rashid Latif Khan University,Lahore,Pakistan
Rana Khalid Mahmood Arshad Rashid Latif College of Pharmacy, Rashid Latif Khan University,Lahore,Pakistan
Waqas Ahmad Rashid Latif College of Pharmacy, Rashid Latif Khan University,Lahore,Pakistan
Abstract
For the simultaneous measurement of Ethinylestradiol (EE) and Drospirenone (DP) in fixed-dose combination hormones tablets, a reverse-phase high-performance liquid chromatographic (RP-HPLC) method was developed. A specific, precise and accurate RP-HPLC method was developed and validated to analyse the drugs in rat plasma. The fluorescence detection for EE was made at ?= 200-310 nm and Ultraviolet-visible (UV/Vis) detection for DP was made at 270 nm. The typical EE and DP retention times were 4.19 and 5.30 minutes, respectively. The limit of detection (LOD) and limit of detection (LOQ) for EE were 0.121 and 0.282µg/mL and LOD and LOQ for DP were 2.23 and 7.697µg/mL respectively. The regression coefficient (r2) of EE and DP were 0.9937 and 0.9913 respectively. Precision's relative standard deviation (RSD) was less than 5%. The analyte recoveries of both drugs stayed within 95% of each other. All other validation parameters adhered to ICH standards. Throughout the analytical process, the analyte was stable. The advantages of the method developed include stability under different conditions and a low limit of quantification that was in micrograms. Its applicability was confirmed by the analysis of EE and DP levels in plasma samples in a designed pharmacokinetic study in rats after oral administration.
Publication Details
Page(s) 1319-1324
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 36, Issue: S4, Year: 2023

Request the full text from PASTIC

Keywords
RP-HPLC, ICH guidelines, simultaneous determination, Ethinylestradiol (EE) and Drospirenone (DP)
References
Ahmed AY,Patel Z,Khan R,Patel H,Azeem SA .2019 .HPLC method validation for the estimation of aspirin in bulk and tablet dosage form as per USP. Int. J. Res. Advent Technol, 7(4S) : 69-73.
Alipanahpour Dil E,Ghaedi M,Asfaram A,Tayebi L,Mehrabi F L .2020 .A ferrofluidic hydrophobic deep eutectic solvent for the extraction of doxycycline from urine, blood plasma and milk samples prior to its determination by high-performance liquid chromatography-ultraviolet. J. Chromatogr. A., 1613 : 460695.
Dalvi AV,Uppuluri CT,Bommireddy EP,Ravi PR .2018 .Design of experiments-based RP-HPLC bioanalytical method development for estimation of Rufinamide in rat plasma and brain and its application in pharmacokinetic study. J. Chromatogr. B., 1102 : 74-82.
Furusho A,Koga R,Akita T,Mita M,Kimura T,Hamase K .2019 .Three-dimensional highperformance liquid chromatographic determination of asn, ser, ala and pro enantiomers in the plasma of patients with chronic kidney disease. J. Anal. Chem, 91(18) : 11569-11575.
Girme A,Pawar S,Ghule C,Shengule S,Saste G,Balasubramaniam AK,Deshmukh A,Hingorani L A .1815 .Bioanalytical method development and validation study of neuroprotective extract of Kashmiri saffron using ultra-fast liquid chromatography-tandem mass spectrometry (UFLC-MS/MS): In vivo pharmacokinetics of apocarotenoids and carotenoids. Mol., 26(6) : .
Gupta DR,Prabhakar B,Wairkar S B .2022 .Non-oral routes, novel formulations and devices of contraceptives: An update. J. Control Release, 345 : 798-810.
Hameedat F,Hawamdeh S,Alnabulsi S,Zayed A .1807 .High performance liquid chromatography (HPLC) with fluorescence detection for quantification of steroids in clinical, pharmaceutical and environmental samples: A Review. Mol., 27(6) : .
Kaza M,Karaźniewicz-Łada M,Kosicka K,Siemiątkowska A,Rudzki PJ .2019 .Bioanalytical method validation: New FDA guidance vs. EMA guideline. Better or worse? J. Pharm. Biomed. Anal., 165 : 381-385.
Kusuma MB,Kashibhatta R,Gavande A,Kiran R,Jagtap S,Vithala P,Moorkoth S,Bhat K S .2021 .Bioanalytical method development and validation of highly selective and sensitive LC-MS/MS method for determination of teriparatide (parathyroid hormone fragment 1-34) in human serum through direct detection of intact teriparatide molecule. J. Chromatogr. B: Anal. Technol, 1187 : 123046.
Magar NR,Shakil PMS .2020 .A review on bioanalytical method development and validation. World J. Pharm. Res, 9 : 1060-1070.
Mehmood Y,Khan IU,Shahzad Y,Khalid SH,Irfan M,Asghar S,Yousaf AM,Hussain T,Khalid I .2019 .Development and validation of a stability-Indicating RP-HPLC method for simultaneous estimation of sofosbuvir and velpatasvir in fixed dose combination tablets and plasma. Pak. J. Pharm. Sci, 32(4) : 1835-1842.
Rajeswari B,Saritha N,Devanna N N .2019 .RP-HPLC method development and validation for the simultaneous estimation of segesterone and ethinyl estradiol in bulk and its pharmaceutical dosage form. Pharma Innov, 8(9) : 176-181.
0

Citations

0

Downloads

58

Views